This invention relates to devices and methods for applying eye drops.
Eye drops are a common treatment for numerous eye ailments including both prescription and non-prescription drops. However, people using conventional eye drop application techniques are often not successful in applying a drop into the conjunctival sac of the eye.
A product is needed to facilitate successful applications of eye drops to ensure successful treatment of eye ailments and prevent wasting medication.
The terms “invention,” “the invention,” “this invention” and “the present invention” used in this patent are intended to refer broadly to all of the subject matter of this patent and the patent claims below. Statements containing these terms should be understood not to limit the subject matter described herein or to limit the meaning or scope of the patent claims below. Embodiments of the invention covered by this patent are defined by the claims below, not this summary. This summary is a high-level overview of various aspects of the invention and introduces some of the concepts that are further described in the Detailed Description section below. This summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to be used in isolation to determine the scope of the claimed subject matter. The subject matter should be understood by reference to appropriate portions of the entire specification of this patent, any or all drawings and each claim.
Disclosed is an eye drop applicator that includes a main body comprising a lower portion and an upper portion attached to the top of the lower portion such that the upper portion includes a cavity for retaining a predetermined amount of medication, and a removable cap configured to cover the cavity. The lower portion may include an opening configured to receive a user's finger.
Illustrative embodiments of the present invention are described in detail below with reference to the following drawing figures.
The subject matter of embodiments of the present invention is described here with specificity to meet statutory requirements, but this description is not necessarily intended to limit the scope of the claims. The claimed subject matter may be embodied in other ways, may include different elements or steps, and may be used in conjunction with other existing or future technologies. This description should not be interpreted as implying any particular order or arrangement among or between various steps or elements except when the order of individual steps or arrangement of elements is explicitly described.
The figures illustrate an exemplary eye drop applicator 100 that facilitates measurement and accurate, effective administration of a medication, such as eye drops or any type of liquid medication. As described in more detail below, the eye drop applicator 100 can securely hold an appropriate amount of medication and facilitates a natural and effective application/delivery of medication.
As illustrated in
As shown in
To accommodate various shapes of users' fingers, the opening 104 of the main body 101 may include a variable diameter D along a height H of the main body 101. As shown in the cross-section view in
As shown in
After the medication 50 is placed in cavity 103 (see
In some examples, the cavity 103 is constructed from medical-grade silicone or any other appropriate material. If desired, the entire upper portion of the eye drop applicator 100 or even the entire eye drop applicator 100 may be constructed from medical-grade silicone or any other appropriate material. To reduce the amount of medical-grade silicone (or other appropriate material) necessary, the lower portion of the eye drop applicator 100 (or all of the eye drop applicator 100 other than the cavity 103) may be constructed from other materials such as rigid plastic, soft plastic, polycarbonate, polyethylene, polyethylene terephthalate, acrylonitrile butadiene styrene, or any other suitable material.
To provide an antimicrobial effect, a surface of one or more components of the eye drop applicator 100 may be treated with a coating either during the manufacturing process or after the manufacturing process is complete. In some examples, the coating may include silver ions and/or particles of a thermoplastic polymer containing an organic biocide where the coating is electrostatically sprayed onto the one or more surfaces (or formed as part of the surfaces during the manufacturing process). In addition, the coating may be any known type of antimicrobial coating. The coating may be applied to the inner surface of the cap 102, to the surface of cavity 103, and/or any other surface of the eye drop applicator 100.
To apply the medication, the eye drop applicator 100 is raised to the recipient's eye 2 similar to the motion for inserting a contact lens such that the portion of the medication 50 protruding from the cavity 103 touches the eye (without touching the eye drop applicator 100 to the eye 2). In some cases, the eye drop applicator 100 may touch the eye 2 and, in some instances, may touch the user's lower eyelid. The contact with the surface of the user's eye 2 disrupts the surface tension of medication 50. After breaking the surface tension, the medication flows from the cavity 103 to the user's eye via gravity or capillary action or a combination of both gravity and capillary action.
Different arrangements of the components depicted in the drawings or described above, as well as components and steps not shown or described are possible. Similarly, some features and subcombinations are useful and may be employed without reference to other features and subcombinations. Embodiments of the invention have been described for illustrative and not restrictive purposes, and alternative embodiments will become apparent to readers of this patent. Accordingly, the present invention is not limited to the embodiments described above or depicted in the drawings, and various embodiments and modifications can be made without departing from the scope of the claims below.
This application is related to and claims priority benefits from U.S. Provisional Application Ser. No. 62/208,940 (“the '940 application”), filed on Aug. 24, 2015, entitled EYE DROP APPLICATOR. The '940 application is hereby incorporated in its entirety by this reference.
Number | Name | Date | Kind |
---|---|---|---|
113601 | Wansleben | Apr 1871 | A |
1336109 | Tullinger | Apr 1920 | A |
20191071 | Carr | Oct 1935 | |
2589499 | Lake | Mar 1952 | A |
2673661 | Barton | Mar 1954 | A |
3016898 | Erwin | Jan 1962 | A |
3958528 | Hill | May 1976 | A |
4085750 | Bosshold | Apr 1978 | A |
D248448 | Mcclure et al. | Jul 1978 | S |
4761381 | Blatt et al. | Aug 1988 | A |
4834728 | McKenna | May 1989 | A |
4913682 | Shabo | Apr 1990 | A |
4960407 | Cope | Oct 1990 | A |
4968310 | Menchel et al. | Nov 1990 | A |
5007905 | Bauer | Apr 1991 | A |
5040706 | Davis et al. | Aug 1991 | A |
5246145 | Leoncavallo et al. | Sep 1993 | A |
5387202 | Baron | Feb 1995 | A |
5611464 | Tsao et al. | Mar 1997 | A |
5756050 | Ershow et al. | May 1998 | A |
5902292 | Feldman | May 1999 | A |
6051190 | Birch et al. | Apr 2000 | A |
6159189 | Finnemore et al. | Dec 2000 | A |
6197008 | Hagele et al. | Mar 2001 | B1 |
6331085 | Schrepf et al. | Dec 2001 | B1 |
6401915 | Faxe | Jun 2002 | B1 |
6632202 | Hagele et al. | Oct 2003 | B1 |
6913406 | Nocerino | Jul 2005 | B1 |
7178703 | Spada et al. | Feb 2007 | B2 |
7476043 | Rivas | Jan 2009 | B1 |
7527613 | Gaynes | May 2009 | B2 |
D597213 | Barnett | Jul 2009 | S |
7678089 | Py et al. | Mar 2010 | B2 |
7758553 | Poisson et al. | Jul 2010 | B2 |
D676126 | Hair | Feb 2013 | S |
8444610 | Grevin et al. | May 2013 | B2 |
8679078 | Leahy et al. | Mar 2014 | B2 |
D736906 | Schultz | Aug 2015 | S |
D743019 | Schultz | Nov 2015 | S |
D763078 | Roy | Aug 2016 | S |
20060129113 | Merrick | Jun 2006 | A1 |
20060198692 | Petit | Sep 2006 | A1 |
20070199831 | Tokarski | Aug 2007 | A1 |
20070287123 | Swift et al. | Dec 2007 | A1 |
20090105749 | de Juan et al. | Apr 2009 | A1 |
20100234319 | Yu | Sep 2010 | A1 |
20110306942 | Thorpe | Dec 2011 | A1 |
20130220851 | Priebe | Aug 2013 | A1 |
20140094759 | Mansfield | Apr 2014 | A1 |
20140350492 | Rojas Escalante et al. | Nov 2014 | A1 |
Number | Date | Country |
---|---|---|
29711373 | Sep 1997 | DE |
2014055676 | Apr 2014 | WO |
2014111802 | Jul 2014 | WO |
Entry |
---|
Notice of Allowance, Design U.S. Appl. No. 29/564,315, dated Oct. 4, 2016, 10 pages. |
Notice of Allowance, Design U.S. Appl. No. 29/545,356, dated Oct. 31, 2016, 11 pages. |
The Newest Unique Designed BPA Free Silicone Travel Bottle/Names of Eye Drops http://www.alibaba.com/product-detail/The-Newest-Unique-Designed-BPA-Free_716366566.html; believed to be available as early as Jun. 16, 2015. |
5pcs Mini Facial Eye Silicone Massage Cup Diameter 6 Mm Cupping Vacuum Chinese http://www.aliexpress.com/item/5pcs-MINI-FACIAL-EYE-SILICONE-MASSAGE-CUP-DIAMETER-6-MM-CUPPING-VACUUM-CHINESE/2021900579.html: believed to be available as early as Jun. 16, 2015. |
Bradley Fixtures Opti-Aid™ Plus Personal Eyewash Station https://www.fishersci.com/shop/products/bradley-fixtures-opti-aid-plus-personal-eyewash-station/p-3526554; believed to be available as early as Jun. 16, 2015. |
https://web.archive.org/web/20110220003150/http://eyepodmagic.com Feb. 20, 2011. |
http://www.prnewswire.com/news-releases/inventor-discovers-a-new-wa y-of-inserting-contact-lens-in-1-second—finger-free-79397202.html.; Dec. 16, 2009. |
http://www.news-medical.net/news/20091211/Hot-Ideas-World-creates-Eye-POD-Eye-Care-Kit.aspx ; Dec. 11, 2009. |
“Lab Supplies.” MidAtlantic Ortho. MidAtlantic Ortho, Aug. 2, 2009. Web. Oct. 1, 2013, http://www.midatlanticortho.com/lab_supplies.php. |
Tiwari, Rajkiran, and D.R. Paul. “Polypropylene-elastomer (TPO) nanocomposites.” Elsevier: Polymer. 52.21 (2011): 4955-4969. Web. Oct. 3, 2013. http://www.sciencedirect.com/science/article/pii/S0032386111006859#. |
Shmulinson, Michal, Mercedes Galan-Fereres, et al. “Formation of Elastomeric Polypropylene Promoted by Racemic Acteylacetonate Group 4 Complexes.” Organometallics. 19 (1999): 1208-1210. Web. Oct. 3, 2013. http://pubs.acs.org/doi/pdf/10.1021/om9908985. |
“Vistamaxx propylene-based elastomer.” ExxonMobil Chemical. N.p., Jan. 29, 2010. Web. Oct. 3, 2013. http://www.exxonmobilchemcial.com/Chem-English/brands/vistamaxx-propylene-based-elastomers.aspx?in=productsservices. |
Non-Final Office Action, Design U.S. Appl. No. 29/545,356, dated Sep. 1, 2016, 8 pages. |
Notice of Allowance, Design U.S. Appl. No. 29/564,315, dated Sep. 2, 2016, 6 pages. |
Office Action, Indian Design Application No. 283265, dated Aug. 9, 2016, 2 pages. |
Number | Date | Country | |
---|---|---|---|
20170056241 A1 | Mar 2017 | US |
Number | Date | Country | |
---|---|---|---|
62208940 | Aug 2015 | US |